{"id":804664,"date":"2022-07-01T19:01:34","date_gmt":"2022-07-01T17:01:34","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/"},"modified":"2022-07-01T19:01:34","modified_gmt":"2022-07-01T17:01:34","slug":"oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/","title":{"rendered":"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer"},"content":{"rendered":"The planned transactions are as follows:\n\n\nThe subsidiarisation by ONCODESIGN of its Biotech\/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary, and the listing of this subsidiary through an exceptional distribution in kind to ONCODESIGN's shareholders concomitant with the admission of all OPM's shares to listing on Euronext Growth\nThe creation of two distinct listed entities, with different corporate purposes which are ambitious, motivating for employees and value-creating for shareholders:\nThe Service activity, dedicated to Drug Discovery CRO activities within ONCODESIGN Service;\nThe Biotech activity, integrating Artificial Intelligence, within OPM. The company will seek to refinance i
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

The planned transactions are as follows: The subsidiarisation by ONCODESIGN of its Biotech\/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary, and the listing of this subsidiary through an exceptional distribution in kind to ONCODESIGN’s shareholders concomitant with the admission of all OPM’s shares to listing on Euronext Growth […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49624],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-804664","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-europe"],"acf":[],"yoast_head":"\nONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer - BeBeez\" \/>\n<meta property=\"og:description\" content=\"The planned transactions are as follows: The subsidiarisation by ONCODESIGN of its Biotech\/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary, and the listing of this subsidiary through an exceptional distribution in kind to ONCODESIGN's shareholders concomitant with the admission of all OPM's shares to listing on Euronext Growth […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-01T17:01:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer\",\"datePublished\":\"2022-07-01T17:01:34+00:00\",\"dateModified\":\"2022-07-01T17:01:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/\"},\"wordCount\":3252,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in Europe\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/\",\"name\":\"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-07-01T17:01:34+00:00\",\"dateModified\":\"2022-07-01T17:01:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/","og_locale":"en_US","og_type":"article","og_title":"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer - BeBeez","og_description":"The planned transactions are as follows: The subsidiarisation by ONCODESIGN of its Biotech\/AI activities through a partial transfer of assets to the ONCODESIGN Precision Medicine (OPM) subsidiary, and the listing of this subsidiary through an exceptional distribution in kind to ONCODESIGN's shareholders concomitant with the admission of all OPM's shares to listing on Euronext Growth […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/","og_site_name":"BeBeez","article_published_time":"2022-07-01T17:01:34+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/"},"author":{"name":"","@id":""},"headline":"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer","datePublished":"2022-07-01T17:01:34+00:00","dateModified":"2022-07-01T17:01:34+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/"},"wordCount":3252,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in Europe"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/","name":"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-07-01T17:01:34+00:00","dateModified":"2022-07-01T17:01:34+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/oncodesign-announces-the-separation-of-its-two-business-lines-service-and-biotech-and-its-entry-into-exclusive-negotiations-with-elyan-partners-for-the-sale-of-a-majority-stake-in\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/804664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=804664"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/804664\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=804664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=804664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=804664"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=804664"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=804664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}